Fennec Pharmaceuticals Stock Market Value
| FENC Stock | USD 7.94 0.03 0.38% |
| Symbol | Fennec |
Will Biotechnology sector continue expanding? Could Fennec diversify its offerings? Factors like these will boost the valuation of Fennec Pharmaceuticals. Market participants price Fennec higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Fennec Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.26) | Revenue Per Share | Quarterly Revenue Growth 0.787 | Return On Assets | Return On Equity |
Understanding Fennec Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Fennec's accounting equity. The concept of intrinsic value - what Fennec Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Fennec Pharmaceuticals' price substantially above or below its fundamental value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Fennec Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Fennec Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fennec Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fennec Pharmaceuticals.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Fennec Pharmaceuticals on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Fennec Pharmaceuticals or generate 0.0% return on investment in Fennec Pharmaceuticals over 90 days. Fennec Pharmaceuticals is related to or competes with Eupraxia Pharmaceuticals, Aardvark Therapeutics, Cartesian Therapeutics, Prelude Therapeutics, Caribou Biosciences, Avalo Therapeutics, and Enanta Pharmaceuticals. Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company More
Fennec Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fennec Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fennec Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 17.84 | |||
| Value At Risk | (4.94) | |||
| Potential Upside | 4.19 |
Fennec Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fennec Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fennec Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Fennec Pharmaceuticals historical prices to predict the future Fennec Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.0006) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.26) | |||
| Treynor Ratio | (0.12) |
Fennec Pharmaceuticals February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.0006) | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 2.1 | |||
| Coefficient Of Variation | (9,097) | |||
| Standard Deviation | 2.9 | |||
| Variance | 8.38 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.26) | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 17.84 | |||
| Value At Risk | (4.94) | |||
| Potential Upside | 4.19 | |||
| Skewness | 0.7309 | |||
| Kurtosis | 2.78 |
Fennec Pharmaceuticals Backtested Returns
At this point, Fennec Pharmaceuticals is slightly risky. Fennec Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0116, which denotes the company had a 0.0116 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Fennec Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Fennec Pharmaceuticals' Standard Deviation of 2.9, mean deviation of 2.1, and Variance of 8.38 to check if the risk estimate we provide is consistent with the expected return of 0.0345%. The firm shows a Beta (market volatility) of 0.36, which means possible diversification benefits within a given portfolio. As returns on the market increase, Fennec Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Fennec Pharmaceuticals is expected to be smaller as well. Fennec Pharmaceuticals right now shows a risk of 2.97%. Please confirm Fennec Pharmaceuticals maximum drawdown, daily balance of power, relative strength index, as well as the relationship between the skewness and day typical price , to decide if Fennec Pharmaceuticals will be following its price patterns.
Auto-correlation | -0.13 |
Insignificant reverse predictability
Fennec Pharmaceuticals has insignificant reverse predictability. Overlapping area represents the amount of predictability between Fennec Pharmaceuticals time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fennec Pharmaceuticals price movement. The serial correlation of -0.13 indicates that less than 13.0% of current Fennec Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.13 | |
| Spearman Rank Test | 0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock:Check out Fennec Pharmaceuticals Correlation, Fennec Pharmaceuticals Volatility and Fennec Pharmaceuticals Performance module to complement your research on Fennec Pharmaceuticals. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Fennec Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.